Improvement of Hemodialysis Catheter Function with Tenecteplase: A Phase III, Open-Label Study: TROPICS 4

Hemodialysis (HD) catheters are prone to thrombotic occlusion. We evaluated tenecteplase, a thrombolytic, for the treatment of dysfunctional HD catheters. Patients with tunneled HD catheters and blood flow rate (BFR)

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of thrombosis and thrombolysis 2011, Vol.31 (1), p.99-106
Hauptverfasser:	Fishbane, Steven, Milligan, Samuel L., Lempert, Kenneth D., Hertel, Joachim E. W., Wetmore, James B., Oliver, Matthew J., Blaney, Martha, Gillespie, Barbara S., Jacobs, Joan R., Begelman, Susan M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Cardiology Catheters Female Fibrinolytic Agents - administration & dosage Fibrinolytic Agents - adverse effects Hematology Humans Male Medicine Medicine & Public Health Middle Aged Renal Dialysis - methods Time Factors Tissue Plasminogen Activator - administration & dosage Tissue Plasminogen Activator - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Hemodialysis (HD) catheters are prone to thrombotic occlusion. We evaluated tenecteplase, a thrombolytic, for the treatment of dysfunctional HD catheters. Patients with tunneled HD catheters and blood flow rate (BFR)
ISSN:	0929-5305 1573-742X
DOI:	10.1007/s11239-010-0493-1